Literature DB >> 31177864

A comprehensive and practical approach to the management of idiopathic pulmonary fibrosis.

Onofre Moran-Mendoza1, Rebecca Colman2, Meena Kalluri3, Czerysh Cabalteja4, Ingrid Harle5.   

Abstract

Introduction: Idiopathic pulmonary fibrosis (IPF) is a debilitating, progressive, and fatal fibrotic pulmonary disease with a prognosis comparable to that of lung cancer. IPF management is a complex process that involves pharmacological and nonpharmacological interventions, extensive patient education, and addressing patient needs that change through the course of the illness. Areas covered: This review summarizes the key aspects of a multifaceted, multidisciplinary, individualized approach to IPF care that incorporates available treatment options, strategies to improve compliance with antifibrotic therapies, pulmonary rehabilitation, and the integration of palliative care for symptom management. Aspects of care discussed include the use of antifibrotic therapy and nonpharmacological treatments, targeted education and psychosocial support, evaluation and management of comorbidities, and early integration of palliative care. Expert opinion: By incorporating this comprehensive approach to disease management, physicians can address most aspects of care for a patient with IPF to optimize survival and quality of life.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis; disease management; disease progression; interstitial lung disease; nintedanib; pirfenidone

Mesh:

Year:  2019        PMID: 31177864     DOI: 10.1080/17476348.2019.1627204

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  1 in total

1.  Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic Therapy.

Authors:  Sebastian Majewski; Maria Królikowska; Ulrich Costabel; Wojciech J Piotrowski; Marek Ochman
Journal:  Case Rep Pulmonol       Date:  2022-08-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.